Logo image of INLX

INTELLINETICS INC (INLX) Stock Fundamental Analysis

NYSEARCA:INLX - NYSE Arca - US45825X2045 - Common Stock - Currency: USD

11.8  +0.3 (+2.63%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to INLX. INLX was compared to 283 industry peers in the Software industry. Both the profitability and the financial health of INLX get a neutral evaluation. Nothing too spectacular is happening here. INLX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year INLX has reported negative net income.
In the past year INLX had a positive cash flow from operations.
In multiple years INLX reported negative net income over the last 5 years.
Of the past 5 years INLX 4 years had a positive operating cash flow.
INLX Yearly Net Income VS EBIT VS OCF VS FCFINLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.91%, INLX is in the better half of the industry, outperforming 62.32% of the companies in the same industry.
INLX has a Return On Equity of 1.66%. This is in the better half of the industry: INLX outperforms 63.04% of its industry peers.
The Return On Invested Capital of INLX (3.70%) is better than 71.74% of its industry peers.
INLX had an Average Return On Invested Capital over the past 3 years of 7.25%. This is below the industry average of 11.91%.
Industry RankSector Rank
ROA 0.91%
ROE 1.66%
ROIC 3.7%
ROA(3y)4.73%
ROA(5y)-44.66%
ROE(3y)18.87%
ROE(5y)N/A
ROIC(3y)7.25%
ROIC(5y)N/A
INLX Yearly ROA, ROE, ROICINLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400 -600

1.3 Margins

Looking at the Profit Margin, with a value of 0.97%, INLX is in the better half of the industry, outperforming 62.68% of the companies in the same industry.
The Operating Margin of INLX (3.78%) is better than 68.84% of its industry peers.
INLX has a Gross Margin (63.85%) which is in line with its industry peers.
In the last couple of years the Gross Margin of INLX has declined.
Industry RankSector Rank
OM 3.78%
PM (TTM) 0.97%
GM 63.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.14%
GM growth 5Y-1.89%
INLX Yearly Profit, Operating, Gross MarginsINLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INLX is destroying value.
The number of shares outstanding for INLX has been increased compared to 1 year ago.
The number of shares outstanding for INLX has been increased compared to 5 years ago.
The debt/assets ratio for INLX has been reduced compared to a year ago.
INLX Yearly Shares OutstandingINLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
INLX Yearly Total Debt VS Total AssetsINLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

An Altman-Z score of 3.03 indicates that INLX is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.03, INLX perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
The Debt to FCF ratio of INLX is 1.08, which is an excellent value as it means it would take INLX, only 1.08 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.08, INLX is in the better half of the industry, outperforming 70.29% of the companies in the same industry.
A Debt/Equity ratio of 0.22 indicates that INLX is not too dependend on debt financing.
INLX's Debt to Equity ratio of 0.22 is in line compared to the rest of the industry. INLX outperforms 42.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.08
Altman-Z 3.03
ROIC/WACC0.27
WACC13.83%
INLX Yearly LT Debt VS Equity VS FCFINLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

INLX has a Current Ratio of 1.11. This is a normal value and indicates that INLX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.11, INLX is not doing good in the industry: 71.38% of the companies in the same industry are doing better.
A Quick Ratio of 1.09 indicates that INLX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.09, INLX is doing worse than 71.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.09
INLX Yearly Current Assets VS Current LiabilitesINLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

4

3. Growth

3.1 Past

INLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -169.44%.
The Revenue has grown by 20.47% in the past year. This is a very strong growth!
The Revenue has been growing by 47.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-169.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-280%
Revenue 1Y (TTM)20.47%
Revenue growth 3Y26.95%
Revenue growth 5Y47.96%
Sales Q2Q%8.03%

3.2 Future

Based on estimates for the next years, INLX will show a very negative growth in Earnings Per Share. The EPS will decrease by -75.32% on average per year.
Based on estimates for the next years, INLX will show a small growth in Revenue. The Revenue will grow by 6.64% on average per year.
EPS Next Y-270%
EPS Next 2Y-75.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.81%
Revenue Next 2Y6.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INLX Yearly Revenue VS EstimatesINLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
INLX Yearly EPS VS EstimatesINLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INLX. In the last year negative earnings were reported.
Also next year INLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INLX Price Earnings VS Forward Price EarningsINLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INLX indicates a somewhat cheap valuation: INLX is cheaper than 75.72% of the companies listed in the same industry.
INLX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INLX is cheaper than 80.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.24
EV/EBITDA 29.1
INLX Per share dataINLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A cheap valuation may be justified as INLX's earnings are expected to decrease with -75.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-75.32%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

INLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTELLINETICS INC

NYSEARCA:INLX (2/21/2025, 8:04:01 PM)

11.8

+0.3 (+2.63%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-26 2025-03-26/amc
Inst Owners4.32%
Inst Owner Change-86.39%
Ins Owners26.42%
Ins Owner Change0%
Market Cap49.91M
Analysts82.86
Price Target19.38 (64.24%)
Short Float %0.24%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.51%
Min EPS beat(2)-198.04%
Max EPS beat(2)-50.98%
EPS beat(4)1
Avg EPS beat(4)-75.49%
Min EPS beat(4)-198.04%
Max EPS beat(4)22.55%
EPS beat(8)4
Avg EPS beat(8)75%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.52%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)4.33%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)4.33%
Revenue beat(8)5
Avg Revenue beat(8)1.82%
Revenue beat(12)8
Avg Revenue beat(12)1.68%
Revenue beat(16)12
Avg Revenue beat(16)3.01%
PT rev (1m)0%
PT rev (3m)60.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-171.43%
EPS NY rev (3m)-171.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.84
P/FCF 23.24
P/OCF 17.81
P/B 4.82
P/tB 215.45
EV/EBITDA 29.1
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.51
FCFY4.3%
OCF(TTM)0.66
OCFY5.62%
SpS4.16
BVpS2.45
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 1.66%
ROCE 4.68%
ROIC 3.7%
ROICexc 4.19%
ROICexgc 21.82%
OM 3.78%
PM (TTM) 0.97%
GM 63.85%
FCFM 12.21%
ROA(3y)4.73%
ROA(5y)-44.66%
ROE(3y)18.87%
ROE(5y)N/A
ROIC(3y)7.25%
ROIC(5y)N/A
ROICexc(3y)8.76%
ROICexc(5y)N/A
ROICexgc(3y)66.35%
ROICexgc(5y)N/A
ROCE(3y)9.18%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.14%
GM growth 5Y-1.89%
F-Score7
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.08
Debt/EBITDA 1.3
Cap/Depr 61.12%
Cap/Sales 3.73%
Interest Coverage 250
Cash Conversion 161.33%
Profit Quality 1253.52%
Current Ratio 1.11
Quick Ratio 1.09
Altman-Z 3.03
F-Score7
WACC13.83%
ROIC/WACC0.27
Cap/Depr(3y)91.92%
Cap/Depr(5y)74.59%
Cap/Sales(3y)4.17%
Cap/Sales(5y)2.73%
Profit Quality(3y)1992.71%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-169.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-280%
EPS Next Y-270%
EPS Next 2Y-75.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20.47%
Revenue growth 3Y26.95%
Revenue growth 5Y47.96%
Sales Q2Q%8.03%
Revenue Next Year6.81%
Revenue Next 2Y6.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-54.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y417.13%
FCF growth 3Y70.02%
FCF growth 5YN/A
OCF growth 1Y220.18%
OCF growth 3Y84.47%
OCF growth 5YN/A